Add Papers Marked0
Paper checked off!

Marked works

Viewed0

Viewed works

Shopping Cart0
Paper added to shopping cart!

Shopping Cart

Register Now

internet library
Atlants.lv library
FAQ
9,99 € Add to cart
Add to Wish List
Want cheaper?
ID number:938264
 
Evaluation:
Published: 08.12.2003.
Language: English
Level: Secondary school
Literature: n/a
References: Not used
Extract

Conclusion and Recommendation
Basically, Pfizer is a very aggressive pharmaceutical company as you will see that they are the no.1 in sales starting from 2001 and maintain for 2 years up till now. Their strong Resources & Development department focusing the need of the pharmaceutical industry and creating up to date products for today's market. Every topest doctor is willing to use Pfizer's product as it represents they are the leader in the pharmaceutical industry but on the other hand, the price is quite expensive.
As Pfizer is so aggressive, the consumption no matter for hospitals and private doctors has already been over the target of the following years so it is quite difficult to have further growth. If the company keeps on adding target to medical representatives, the outcome would become negative. So, Pfizer is better to slow down their strategic a little bit that to let the outside consumption to be digest first than to make further increment.
Outside competitor like AstraZeneca is following Pfizer's strategic to expand their business. AstraZeneca is very famous in United Kingdom and going to increase the market share in Hong Kong so Pfizer needs to aware this competitor and make necessary arrangements.

Work pack:
GREAT DEAL buying in a pack your savings −5,98 €
Work pack Nr. 1275752
Load more similar papers

Atlants

Choose Authorization Method

Email & Password

Email & Password

Wrong e-mail adress or password!
Log In

Forgot your password?

Draugiem.pase
Facebook

Not registered yet?

Register and redeem free papers!

To receive free papers from Atlants.com it is necessary to register. It's quick and will only take a few seconds.

If you have already registered, simply to access the free content.

Cancel Register